DNA Sequencing Market Size to Reach USD 11.28 Billion by 2027; CAGR of 11.3% | Top key Players Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN

DNA Sequencing Market Size to Reach USD 11.28 Billion by 2027; CAGR of 11.3% | Top key Players Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN
Government initiatives for large scale DNA sequencing-based projects, collaborations for technical advancements, and declining costs are key factors driving the market demand.

The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. The market for DNA sequencing is experiencing high demand owing to its applications in biomarker discovery, personalized medicine, oncology studies, forensics, and others. Its demand has increased due to a surge in sequencing applications and advancement in technology in DNA sequencing. Growth in R&D investment is also encouraging the growth of the market.

Other factors propelling the demand for the market are growing partnerships and collaboration among market players and a rise in genome mapping programs all across the globe. Increased investment in research and development activities provides a lucrative opportunity for the industry. However, standardization concerns and legal & ethical limitations accredited with DNA sequencing hamper the demand for the market.

Request a Sample Copy of the Research Report @ https://www.reportsanddata.com/sample-enquiry-form/3705

Leading Players Profiled in the Report Include:

Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN, Illumina, Inc., F. Hoffmann-La Roche Ltd., Macrogen, Inc., Oxford Nanopore Technologies, Pacific Biosciences Of California, Inc., Perkin Elmer, Inc., and Bio-Rad Laboratories, Inc., among others.

The COVID-19 impact:

The distribution of Covid-19’s has influenced industrial activities worldwide. Pharma company manufacturers are at the forefront of human response to the COVID-19 pandemic. An increase in the number of biotech firms to explore and develop a vaccine for the virus has developed a strict competition. DNA sequencing is playing a crucial role in the development of therapies for chronic diseases at an unprecedented rate, and a substantial amount of funds are being put into the research and development of the market product. The market will witness an increased demand in the coming years.

Further key findings from the report suggest

  • The consumables segment held the largest share due to the wide availability of kits and reagents to cater to DNA fragmentation, amplification, fragmentation enrichment, and quality control, which contributes to the growth of the product and services segment.
  • Next-Generation Sequencing (NGS) is anticipated to witness diversification into a substantial number of clinical areas due to the reduction in cost. At present, next-generation sequencing is acknowledged to be the leading technology responsible for the burgeoning field of oncology, Mendelian diseases, and complex disease testing.
  • Pharmaceutical companies are making use of the available genomic information in personalized medicine, which is forecasted to significantly impact the growth of the market. The reduction in the cost of sequencing has made it more attractive to pharmaceutical and biotechnology companies.
  • North America remains the key revenue-generating geographical segment in the DNA sequencing market. The availability of research funds from the public as well as private sources, availability of state-of-art technologies, and presence of key market players in the region are among the key factors driving the market growth in this region.

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/3705

For the purpose of this report, Reports and Data has segmented into the Global DNA Sequencing Market on the basis of product and services, technology, application, end-user, and region:

Product and Services Outlook (Revenue, USD Billion; 2017-2027)

  • Consumables
  • Instruments
  • Services

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Next-Generation Sequencing
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Targeted Sequencing & Resequencing
  • Sanger Sequencing
  • Third-Generation Sequencing
    • Single-molecule real-time sequencing (SMRT)
    • Nanopore sequencing

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Reproductive Health
  • Oncology
  • Agrigenomics & Forensics
  • Clinical Investigation
  • Metagenomics, Epidemiology & Drug Development
  • HLA Typing/Immune System Monitoring
  • Consumer Genomics
  • Others

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Clinics
  • Clinical Research
  • Academic Research

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • MEA
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • Latin America
    • Brazil
    • Rest of LATAM

Request for Customization @ https://www.reportsanddata.com/request-customization-form/3705

Table of contents           

Chapter 1.    Market Synopsis

    1.1.    Market Definition

    1.2.    Research Scope & Premise

    1.3.    Methodology

    1.4.    Market Estimation Technique

Chapter 2.    Executive Summary

    2.1.    Summary Snapshot, 2019-2027

Chapter 3.    Indicative Metrics

Chapter 4.    DNA Sequencing Market Segmentation & Impact Analysis

    4.1.    DNA Sequencing Market Material Segmentation Analysis

    4.2.    Industrial Outlook

          4.2.1.    Market indicators analysis

          4.2.2.    Market drivers analysis

            Rise in incidence of genetic disorders and cancer

            Technological advancements in sequencing techniques and data integration

            Declining cost of genetic sequencing

          4.2.3.    Market restraints analysis

             Limitations associated with DNA sequencing

    4.3.    Technological Insights

    4.4.    Regulatory Framework

    4.5.    ETOP Analysis

    4.6.    Porter’s Five Forces Analysis

    4.7.    Competitive Metric Space Analysis

    4.8.    Price trend Analysis

    4.9.    Customer Mapping

    4.10.    Covid-19 Impact Analysis

    4.11.    Global Recession Influence


Have Any Query? Ask Our Experts @ https://www.reportsanddata.com/speak-to-analyst-form/3705

Thank you for reading our report. In case of further queries regarding the report or inquiry about its customization, please connect with us. We will ensure your report is well-suited to your requirements.

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/dna-sequencing-market